search
Back to results

Post Prandial Glucose Control Proof-of-Principle

Primary Purpose

Diabetes Mellitus, Type 2

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Carbohydrate placebo
Nutritional ingredient
#1 Nutritional ingredient +Fiber
#2 Nutritional ingredient + Fiber
#3 Nutritional ingredient + Fiber
Sponsored by
Abbott Nutrition
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus, Type 2

Eligibility Criteria

21 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. type 2 diabetes
  2. between 21 and 75 years of age
  3. male or a non-pregnant, non-lactating female, at least 6 weeks postpartum or postmenopausal or surgically sterile
  4. BMI is > 18.5 kg/m2 and <35 kg/m2
  5. HbA1c < 9.0%

Exclusion Criteria:

  1. Subject uses exogenous insulin, exenatide, or sitagliptin phosphate
  2. type 1 diabetes.
  3. history of diabetic ketoacidosis.
  4. current infection
  5. active malignancy
  6. has had a significant cardiovascular event or history of congestive heart failure.
  7. end-stage organ failure or post organ transplant.
  8. history of renal disease.
  9. hepatic disease.
  10. history of gastrointestinal disorders
  11. chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.
  12. taking any herbals, dietary supplements, or medications, other than oral hypoglycemic medications
  13. clotting or bleeding disorders.
  14. allergic or intolerant to any ingredient found in the study products.

Sites / Locations

  • Radiant Research

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

Active Comparator

Placebo Comparator

Experimental

Experimental

Experimental

Arm Label

Nutritional ingredient

Carbohydrate

#1 Nutrtitional ingredient + Fiber

#2 Nutritional ingredient + Fiber

#3 Nutritional ingredient + Fiber

Arm Description

Dissolve in water and consume with meal

dissolve in water and consume with meal

Dissolve in water and consume with meal

Dissolve in water and consume with meal

Dissolve in water and consume with meal

Outcomes

Primary Outcome Measures

Positive AUC from 0 to 240 minutes for plasma glucose.

Secondary Outcome Measures

Plasma glucose concentrations

Full Information

First Posted
March 28, 2011
Last Updated
March 29, 2011
Sponsor
Abbott Nutrition
search

1. Study Identification

Unique Protocol Identification Number
NCT01326299
Brief Title
Post Prandial Glucose Control Proof-of-Principle
Official Title
Post Prandial Glucose Control Proof-of-Principle
Study Type
Interventional

2. Study Status

Record Verification Date
March 2011
Overall Recruitment Status
Completed
Study Start Date
August 2010 (undefined)
Primary Completion Date
September 2010 (Actual)
Study Completion Date
September 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Abbott Nutrition

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to compare the postprandial glycemic response of subjects with type 2 diabetes when consuming a meal along with beverages containing various combinations of nutritional ingredients and fibers versus control beverage.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Nutritional ingredient
Arm Type
Active Comparator
Arm Description
Dissolve in water and consume with meal
Arm Title
Carbohydrate
Arm Type
Placebo Comparator
Arm Description
dissolve in water and consume with meal
Arm Title
#1 Nutrtitional ingredient + Fiber
Arm Type
Experimental
Arm Description
Dissolve in water and consume with meal
Arm Title
#2 Nutritional ingredient + Fiber
Arm Type
Experimental
Arm Description
Dissolve in water and consume with meal
Arm Title
#3 Nutritional ingredient + Fiber
Arm Type
Experimental
Arm Description
Dissolve in water and consume with meal
Intervention Type
Other
Intervention Name(s)
Carbohydrate placebo
Intervention Description
dissolve in water and consume with meal
Intervention Type
Other
Intervention Name(s)
Nutritional ingredient
Intervention Description
Dissolve in water and consume with meals
Intervention Type
Other
Intervention Name(s)
#1 Nutritional ingredient +Fiber
Intervention Description
Dissolve in water and consume with meal
Intervention Type
Other
Intervention Name(s)
#2 Nutritional ingredient + Fiber
Intervention Description
Dissolve in water and consume with meal
Intervention Type
Other
Intervention Name(s)
#3 Nutritional ingredient + Fiber
Intervention Description
Dissolve in water and consume with meal
Primary Outcome Measure Information:
Title
Positive AUC from 0 to 240 minutes for plasma glucose.
Time Frame
0 to 240 minutes
Secondary Outcome Measure Information:
Title
Plasma glucose concentrations
Time Frame
0 to 240 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: type 2 diabetes between 21 and 75 years of age male or a non-pregnant, non-lactating female, at least 6 weeks postpartum or postmenopausal or surgically sterile BMI is > 18.5 kg/m2 and <35 kg/m2 HbA1c < 9.0% Exclusion Criteria: Subject uses exogenous insulin, exenatide, or sitagliptin phosphate type 1 diabetes. history of diabetic ketoacidosis. current infection active malignancy has had a significant cardiovascular event or history of congestive heart failure. end-stage organ failure or post organ transplant. history of renal disease. hepatic disease. history of gastrointestinal disorders chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV. taking any herbals, dietary supplements, or medications, other than oral hypoglycemic medications clotting or bleeding disorders. allergic or intolerant to any ingredient found in the study products.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Amy Devitt-Maicher, PhD
Organizational Affiliation
Abbott Nutrition
Official's Role
Study Chair
Facility Information:
Facility Name
Radiant Research
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45249
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Post Prandial Glucose Control Proof-of-Principle

We'll reach out to this number within 24 hrs